Vertex Pharma obtains exclusive license to TreeFrog's C-Stem to optimize production of its cell therapies for type 1 diabetes: Boston Wednesday, April 24, 2024, 15:00 Hrs [IST] Ve ...
Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc. (Par), is expanding its voluntary recall to include seven lots of Treprostinil Injection 20mg/20mL ...
Roche signs MoU with VinCense to augment access to diabetes care in Tamil Nadu: Our Bureau, Mumbai Wednesday, April 24, 2024, 17:15 Hrs [IST] Roche announced that the company has ...
Benchling, a company creates the software that powers the biotechnology industry, announced that Zealand Pharma A/S, (Zealand) a biotechnology company focused on the discovery and development of ...
ZYUS Life Sciences Corporation, a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, ...
Pfizer’s Emblaveo receives European marketing approval for patients with multidrug-resistant infections and limited treatment options: New York Wednesday, April 24, 2024, 09:00 ...
Sanofi’s LUNA 3 phase 3 study of rilzabrutinib in patients with immune thrombocytopenia meets primary endpoint: Paris Wednesday, April 24, 2024, 12:00 Hrs [IST] Positive results ...
EU approves Voydeya as an add-on treatment to ravulizumab or eculizumab for adults with rare disease PNH who have residual haemolytic anaemia: Cambridge, UK Wednesday, April 24, 2 ...
Lupin receives EIR from US FDA for its Aurangabad manufacturing facility: Our Bureau, Mumbai Wednesday, April 24, 2024, 13:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) a ...
Sandoz, the global leader in generic and biosimilar medicines, announces that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab), developed and ...
Moderna enters contract with Brazil to supply 12.5 million Covid-19 vaccines as part of national vaccination campaign: Cambridge, Massachusetts Wednesday, April 24, 2024, 11:00 Hr ...
Lilly buys FDA-approved new injectable medicine manufacturing facility from Nexus Pharma: Indianapolis Wednesday, April 24, 2024, 10:00 Hrs [IST] Eli Lilly and Company and Nexus P ...